Myong-Jin Kim, Pharm.D.

US Food and Drug Administration

Poster(s):

• (W0930-10-64) A Science-Based Approach for Recommendation of Antagonist Blockade in the Bioequivalence Studies of Opioid Drug Products
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET

• (M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (T1330-04-26) Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine: Physiologically Based Pharmacokinetic Modeling
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (W0930-03-20) In Vitro Evaluation of Two Morphine Sulfate Extended-Release Products Sprinkled on Soft Foods
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET